EGFR and prostate carcinoma: A large number of successfully retargeted AdVs towards neuronal cells, brain endothelial cells, vascular endothelial cells, prostate cancer, lung cancer, pancreatic cancer, muscle cells, and receptors-like epidermal growth factor receptor (EGFR) have been reported [66,67,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99].